{"schema_version":"secwatch.filing_event.v1","accession":"0001323885-25-000005","form_type":"8-K","ticker":"ATRC","cik":"0001323885","company_name":"AtriCure, Inc.","filed_at":"2025-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.291068+00:00","generated_at":"2026-05-26T22:45:47.483006+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"AtriCure Q4 revenue $124.3M (+16.6% YoY); guides FY25 rev $517-527M","bullets":["Q4 revenue $124.3M (+16.6%); full year revenue $465.3M (+16.5%).","Q4 GAAP net loss $0.33/sh; adj. loss $0.08/sh; adj. EBITDA positive $12.7M.","Full year 2024 adj. EBITDA $31.1M (vs $19.4M in 2023); adj. loss $0.67/sh (vs $0.75).","Launched cryoSPHERE+, cryoSPHERE MAX, AtriClip FLEX-Mini in US, EnCompass clamp in Europe.","FY2025 guidance: rev $517-527M; adj. EBITDA $42-44M; adj. loss $0.57-0.64/sh."],"urls":{"canonical":"https://secwatch.observer/filing/0001323885-25-000005","json":"https://secwatch.observer/filing/0001323885-25-000005.json","markdown":"https://secwatch.observer/filing/0001323885-25-000005.md","text":"https://secwatch.observer/filing/0001323885-25-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1323885/000132388525000005/0001323885-25-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1323885/000132388525000005/atrc-20250212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T22:45:47.483006+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}